On top of 348 known job cuts across the organization last year, Roche’s Genentech division laid off an additional 141 ...

Roche is continuing its return to the RNA space by paying $200 million for the worldwide license to one of SanegeneBio’s ...

The Philadelphia Department of Commerce awarded $450,000 in matching grants to local life sciences companies in January. The funds will match the amount companies have received from federal Small ...

Genentech's CEO told the Business Times that a massive renovation set to begin in South San Francisco is meant to reimagine ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new late-breaking data from the Phase III FENtrepid study showing the investigational Bruton’s tyrosine kinase (BTK ...

Genentech’s $2-billion North Carolina biomanufacturing expansion mid-build tests how power, water and labor constraints are shaping advanced manufacturing construction.

The deal provides SanegeneBio with an upfront payment of $200m.

Under the agreement, SanegeneBio has granted Genentech exclusive worldwide rights to develop and commercialize the undisclosed program.

The 700,000-square-foot project broke ground in August and is set to produce weight-loss treatments by 2029 in Holly Springs, a growing biopharmaceutical hub.

Genentech is honing in on an aspect of the patient community that is too often overlooked — the role of caregivers in managing rare diseases. In a recently-released short film, Genentech tells the ...

Jan 20 (Reuters) - Roche's Genentech said on Tuesday it will more than double its initial investment in a biomanufacturing facility in North Carolina to about $2 billion, as the companies look to ...